Influence of congestive heart failure on prazosin kinetics. 1979

P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke

The kinetics of oral prazosin was studied in 10 healthy normal subjects (NS) and in 9 patients with congestive heart failure (CHF). NS received a single 5-mg dose, and blood concentrations of prazosin (CB) were measured, using a specific HPLC assay, during an 8-hr period. CHF patients received a 2-mg dose after which CB was measured for 10 hr. These patients then received 2 to 5 mg prazosin every 8 hr for 48 hr. After the last dose of prazosin, CB was measured for 24 hr. After the initial dose, time to peak CB did not differ significantly between that of the NS (123 +/- 19 SEM min) and of patients with CHF (132 +/- 31.3 min). AUC/mg prazosin was greater (p less than 0.001) in patients with CHF (3,385 +/- 380 Ng x min/ml) than in NS (1,603 +/- 208 ng x min/ml). Elimination of prazosin from blood was slower in CHF patients (t1/2 = 374 +/- 33.4 min) than in NS (t1/2 = 144.5 +/- 4.3 min) (p less than 0.001). These data suggest that in patients with CHF the elimination of prazosin is substantially slower than in NS and therefore higher steady-state prazosin concentrations can be expected in CHF patients than in NS.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke
December 1982, American heart journal,
P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke
January 1978, Bollettino della Societa italiana di cardiologia,
P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke
June 1980, European journal of clinical pharmacology,
P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke
September 1980, Clinical pharmacology and therapeutics,
P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke
September 1981, American heart journal,
P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke
February 1998, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke
June 1980, Archives des maladies du coeur et des vaisseaux,
P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke
June 1991, Clinical cardiology,
P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke
January 1982, Acta medica Scandinavica,
P Jaillon, and P Rubin, and Y G Yee, and R Ball, and R Kates, and D Harrison, and T Blaschke
February 1978, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!